139 related articles for article (PubMed ID: 30826169)
1. The prognostic significance of nodal disease burden in patients with lymph node metastases from renal cell carcinoma.
Zareba P; Russo P
Urol Oncol; 2019 May; 37(5):302.e1-302.e6. PubMed ID: 30826169
[TBL] [Abstract][Full Text] [Related]
2. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
[TBL] [Abstract][Full Text] [Related]
3. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
[TBL] [Abstract][Full Text] [Related]
4. Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy.
Kuusk T; Klatte T; Zondervan P; Lagerveld B; Graafland N; Hendricksen K; Capitanio U; Minervini A; Stewart GD; Ljungberg B; Horenblas S; Bex A
World J Urol; 2021 Sep; 39(9):3377-3383. PubMed ID: 33634323
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.
Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Positive Lymph Nodes in Patients with Renal Cell Carcinoma and Tumor Thrombus Undergoing Nephrectomy and Thrombectomy.
Xiao R; Xu C; Ge L; He W; Yang B; Liu L; Liu C; Ma L
Urol Int; 2021; 105(7-8):657-665. PubMed ID: 33882508
[TBL] [Abstract][Full Text] [Related]
7. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
8. Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract.
Zareba P; Rosenzweig B; Winer AG; Coleman JA
Cancer; 2017 May; 123(10):1741-1750. PubMed ID: 28152158
[TBL] [Abstract][Full Text] [Related]
9. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.
Yu KJ; Keskin SK; Meissner MA; Petros FG; Wang X; Borregales LD; Gu C; Tamboli P; Matin SF; Wood CG; Karam JA
Cancer; 2018 Oct; 124(20):4023-4031. PubMed ID: 30276798
[TBL] [Abstract][Full Text] [Related]
11. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
[TBL] [Abstract][Full Text] [Related]
12. [Renal cell carcinoma].
Shimazui T; Kawai K; Akaza H
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2073-5. PubMed ID: 15570943
[TBL] [Abstract][Full Text] [Related]
13. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases.
Giberti C; Oneto F; Martorana G; Rovida S; Carmignani G
Eur Urol; 1997; 31(1):40-8. PubMed ID: 9032533
[TBL] [Abstract][Full Text] [Related]
14. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract][Full Text] [Related]
16. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
[TBL] [Abstract][Full Text] [Related]
17. Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.
Saltzman AF; Stokes W; Walker J; Cost NG
J Pediatr Urol; 2019 May; 15(3):259.e1-259.e7. PubMed ID: 30819622
[TBL] [Abstract][Full Text] [Related]
18. Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.
Kuusk T; De Bruijn R; Brouwer OR; De Jong J; Donswijk M; Hendricksen K; Horenblas S; Jóźwiak K; Prevoo W; Valdés Olmos RA; Van Der Poel HG; Van Rhijn BW; Wit EM; Bex A
Scand J Urol; 2018; 52(5-6):411-418. PubMed ID: 30526184
[TBL] [Abstract][Full Text] [Related]
19. Reassessing the current TNM lymph node staging for renal cell carcinoma.
Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
[TBL] [Abstract][Full Text] [Related]
20. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]